Diagnosis and management of COPD

E-poster session
Chairs: L. Cestelli (Bergen, Norway), P. Sivapalan (Hellerup, Denmark), A. Papi (Ferrara, Italy)

Variability in eosinophil levels at start of severe exacerbations of COPD E. Citgez (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands), P. Van Der Valk (Enschede, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Brusse-Keizer (Enschede, Netherlands)
Frailty and Risk of COPD Readmission within 30 Days Following Exacerbation of COPD J. Alqahtani (London, United Kingdom), T. Kapdee (London, United Kingdom), S. Quaderi (London, United Kingdom), A. Aldhahir (London, United Kingdom), S. Mandal (London, United Kingdom), J. Hurst (London, United Kingdom)
Association between airway bacterial abundance and urinary inflammatory biomarkers in COPD A. Yousuf (Leicester, United Kingdom), V. Mistry (Leicester, United Kingdom), L. Carr (Leicester, United Kingdom), G. Parekh (Bedford, United Kingdom), M. Yavari Ramsheh (Leicester, United Kingdom), S. Parker (Leicester, United Kingdom), J. Finch (Leicester, United Kingdom), S. Glover (Leicester, United Kingdom), L. Watson (Bedford, United Kingdom), C. Brightling (Leicester, United Kingdom)
Significant parameters in CBC profiles for expecting outcomes of COPD J. YOON (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), E. Heo (Seoul, Republic of Korea), C. Lee (Seoul, Republic of Korea), H. Yoon (Seongnam, Republic of Korea), Y. Hwang (Anyang, Republic of Korea), C. Rhee (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), H. Chung (Seoul, Republic of Korea), D. Kim (Seoul, Republic of Korea)
SERUM ?-2-MICROGLOBULIN CORRELATES WITH COPD OUTCOMES AND PREDICTS FUTURE HOSPITALIZATION. C. Amado Diago (Santander (Cantabria), Spain), A. Guerra (Santander (Cantabria), Spain), M. García-Unzueta (Santander (Cantabria), Spain), J. Agüero (Santander (Cantabria), Spain), S. Tello (Santander (Cantabria), Spain), M. Cristeto (Santander (Cantabria), Spain), J. Osorio (Santander (Cantabria), Spain), S. Izquierdo (Santander (Cantabria), Spain), G. Andretta (Santander (Cantabria), Spain), K. Escobar (Santander (Cantabria), Spain)
Influence of pneumonia on the survival of patients with COPD Z. Ji (Madrid, Spain), J. Hernández Vázquez (Madrid, Spain), C. Castro Riera (Madrid, Spain), J. Bellón Cano (Madrid, Spain), V. Gallo González (Madrid, Spain), B. Recio Moreno (Madrid, Spain), A. Cerezo Lajas (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. De Miguel Díez (Madrid, Spain)
Younger COPD patients – the need for long-term follow-up I. Krachunov (Pleven, Bulgaria), Z. Ivanova (Pleven, Bulgaria), N. Kyuchukov (Pleven, Bulgaria), T. Ignatova-Danova (Pleven, Bulgaria), P. Glogovska (Pleven, Bulgaria), P. Pavlov (Pleven, Bulgaria), T. Popova (Pleven, Bulgaria), E. Borisova (Pleven, Bulgaria), Y. Ivanov (Pleven, Bulgaria)
Automated telephone message service for people with uncontrolled asthma or COPD J. Longstaff (Portsmouth (Hampshire), United Kingdom), M. Chauhan (Portsmouth (Hampshire), United Kingdom), R. De Vos (Portsmouth (Hampshire), United Kingdom), T. Brown (Portsmouth (Hampshire), United Kingdom), R. Jackson (Chertsey, Surrey, United Kingdom), P. Hayward (Chertsey, Surrey, United Kingdom), H. Rupani (Portsmouth (Hampshire), United Kingdom), A. Chauhan (Portsmouth (Hampshire), United Kingdom)
Should anxiety and depression be more deeply researched in COPD? A. Aramburu Ojembarrena (Galdakao, Spain), A. Antón (Galdakao, Spain), F. Moraza (Galdakao, Spain), L. Chasco (Galdakao, Spain), A. Jodar (Galdakao, Spain), M. Gorordo (Galdakao, Spain), S. Aizpiri (Galdakao, Spain), J. Quintana (Galdakao, Spain), C. Esteban (Galdakao, Spain)
The 'surprise question' in patients surviving severe COPD exacerbation. S. Gillespie (Newcastle Upon Tyne, United Kingdom), N. Lane (Newcastle Upon Tyne, United Kingdom), C. Echevarria (Newcastle Upon Tyne, United Kingdom), K. Frew (Newcastle Upon Tyne, United Kingdom), S. Bourke (Newcastle Upon Tyne, United Kingdom)
Copeptin predicts all-cause mortality in stable COPD: An analysis of the COSYCONET study S. Fähndrich (Freiburg, Germany), C. Herr (Homburg/Saar, Germany), H. Watz (Grosshansdorf, Germany), B. Waschki (Grosshansdorf/Hamburg, Germany), J. Classen (Homburg/Saar, Germany), J. Demandt (Homburg/Saar, Germany), F. Trudzinski (Heidelberg, Germany), A. Omlor (Homburg/Saar, Germany), F. Seiler (Homburg/Saar, Germany), T. Welte (Hannover, Germany), H. Kauczor (Heidelberg, Germany), R. Jörres (Munich, Germany), C. Vogelmeier (Marburg, Germany), R. Bals (Homburg/Saar, Germany)
Analysis of NEWS2 trend to predict risk of death in COPD S. Forster (Nottingham, United Kingdom), T. Mckeever (Nottingham, United Kingdom), D. Shaw (Nottingham, United Kingdom)
Examining the correlation between length of hospital stay and disease severity in patients with COPD K. Hansen (Vejle, Denmark), L. Kristensen (Kolding, Denmark), O. Hilberg (Vejle, Denmark), A. Løkke (Vejle, Denmark)
30-day Readmissions After Acute Exacerbations of COPD: How Relevant Are Comorbidities? C. Freitas (Porto, Portugal), J. Dias (Porto, Portugal), P. Leuschner (Porto, Portugal)
Valdation study of MEP-questionnaire for detection of exacerbations (Ebs) - interim analysis T. Hering (Berlin, Germany), N. Kossack (Leipzig, Germany), A. Krinner (Leipzig, Germany), D. Bulenda (Heidenheim, Germany)
Fast time estimation is associated with high levels of depression in COPD patients N. Evgeniev (Ruse, Bulgaria), N. Conev (Varna, Bulgaria), R. Nikolaeva (Ruse, Bulgaria), I. Donev (Ruse, Bulgaria)
The diagnostic value of FEV6/FVC in COPD patients with severe bronchial obstruction I. Nemish (Chernivci, Ukraine), G. Stupnytska (Chernivci, Ukraine), O. Fediv (Chernivci, Ukraine), O. Nesterovska (Chernivci, Ukraine)
The effect of awareness campaigns for early detection of obstructive lung disease R. Nedelcu (Bucuresti, Romania), R. Nemes (Bucuresti, Romania), R. Ulmeanu (Bucuresti, Romania), F. Mihaltan (Bucuresti, Romania)
Comparison of COPD patients with and without diabetes mellitus N. Aksel (Izmir, Turkey), H. Sahin (Izmir, Turkey), I. Naz Gursan (Izmir, Turkey)
Predictive factors of lung function in patients with COPD and heart failure N. MARTINEZ LUNA (Mexico City, Mexico), D. Gonzalez Islas (Mexico City, Mexico), A. Orea Tejeda (Mexico City, Mexico), M. Gómez Martinez (Mexico City, Mexico), Y. Gatelum Ayala (Mexico City, Mexico), Ó. Martinez Reyna (Mexico City, Mexico), V. Martinez Vazquez (Mexico City, Mexico), I. Perez Garcia (Mexico City, Mexico), M. Quintero Martinez (Mexico City, Mexico), I. Sandoval Sanchez (Mexico City, Mexico), L. Verdeja Vendrell (Mexico City, Mexico), R. Sanchez Santillan (Mexico City, Mexico), J. Orozco Gutierrez (Mexico City, Mexico), S. Montoya Azpeitia (Mexico City, Mexico)